SUR1 ‐ TRPM4 Regulates Aquaporin‐4 Subcellular Localization by Astrocytic Endfeet Calcium Signals Following Status Epilepticus
Glia · 2025-10 · 73 (10) · 2057-2076
DOI: 10.1002/glia.70056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, online erschienen am 09.07.2025. Verfasst von Tingting Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Astrocytes, Aquaporin 4, TRPM Cation Channels, Status Epilepticus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Dean Foundation of Nanfang Hospital, Southern Medical University, Basic and Applied Basic Research Foundation of Guangdong Province, Guangzhou Municipal Science and Technology Program Key Project.
Abstract (Originalsprache)
Status epilepticus (SE) is a severe condition that results in uncontrollable cerebral edema and cognitive dysfunction. Recent studies suggest that the localization of aquaporin‐4 (AQP4) in astrocytic endfeet plays a crucial role in regulating blood–brain water transport and cell volume control, particularly along perivascular pathways. However, the signaling mechanisms underlying AQP4 localization remain poorly understood. In this study, we utilized the genetically encoded fluorescent calcium (Ca 2+ ) indicator GCaMp6f to investigate Ca 2+ signals in astrocytic somata, processes, and endfeet during SE induction and observed enhanced Ca 2+ signals in both the somata and perivascular endfeet of astrocytes. We employed genetic knockout of TRPM4 ( Trpm4 −/− ) and glibenclamide treatment to explore the role of sulfonylurea receptor 1 transient receptor potential melastatin‐4 (SUR1‐TRPM4) channel in these Ca 2+ responses. Both approaches significantly suppressed the Ca 2+ signals in the astrocytic endfeet and reduced perivascular expression of the Ca 2+ ‐related signaling pathway sensor calmodulin (CaM). Furthermore, we found that AQP4 localization was no longer confined to the domains of astrocytic endfeet following SE. Inhibition of SUR1‐TRPM4 through pharmacological blockade or gene deletion restored the subcellular localization of AQP4, reduced cerebral edema, and improved cognitive outcomes post‐SE. Our findings suggest that SUR1‐TRPM4 plays a pivotal role in regulating astrocytic Ca 2+ signals and mediating the aberrant expression and subcellular localization of astrocytic AQP4 along perivascular pathways. Together, these findings demonstrate a novel molecular mechanism underscoring SUR1‐TRPM4 therapy in the treatment of SE characterized by dysregulated Ca 2+ signaling in astrocytic endfeet.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
ORCID-Profile: Suyue Pan
Förderung
- Dean Foundation of Nanfang Hospital, Southern Medical University
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangzhou Municipal Science and Technology Program Key Project
- National Natural Science Foundation of China
Zitieren
APA
Yang, T., Lin, Z., Yu, M., Li, Y., Chen, J., Liu, Y., Huang, K., & Pan, S. (2025). SUR1 ‐ TRPM4 Regulates Aquaporin‐4 Subcellular Localization by Astrocytic Endfeet Calcium Signals Following Status Epilepticus. Glia, 73(10), 2057-2076. https://doi.org/10.1002/glia.70056
Vancouver
Yang T, Lin Z, Yu M, Li Y, Chen J, Liu Y, et al. SUR1 ‐ TRPM4 Regulates Aquaporin‐4 Subcellular Localization by Astrocytic Endfeet Calcium Signals Following Status Epilepticus. Glia. 2025;73(10):2057-2076. doi:10.1002/glia.70056
BibTeX
@article{Yang2025,
author = {Yang, Tingting and Lin, Zhenzhou and Yu, Mingjia and Li, Yongchuan and Chen, Jiancong and Liu, Yuanchi and Huang, Kaibin and Pan, Suyue},
title = {SUR1 ‐ TRPM4 Regulates Aquaporin‐4 Subcellular Localization by Astrocytic Endfeet Calcium Signals Following Status Epilepticus},
journal = {Glia},
year = {2025},
volume = {73},
number = {10},
pages = {2057--2076},
doi = {10.1002/glia.70056}
}
EUVIMED